Related references
Note: Only part of the references are listed.Type I interferon-activated microglia are critical for neuromyelitis optica pathology
Agnieszka Wlodarczyk et al.
GLIA (2021)
Neuromyelitis optica in patients with increased interferon alpha concentrations
Jac Williams et al.
LANCET NEUROLOGY (2020)
Astrocyte-microglia interaction drives evolving neuromyelitis optica lesion
Tingjun Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Neuromyelitis optica
Sven Jarius et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
S. J. Pittock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
Axel Petzold et al.
LANCET NEUROLOGY (2017)
Neuromyelitis Spectrum Disorders
Brian G. Weinshenker et al.
MAYO CLINIC PROCEEDINGS (2017)
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography
J. L. Bennett et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Challenges and opportunities in designing clinical trials for neuromyelitis optica
Brian G. Weinshenker et al.
NEUROLOGY (2015)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography
J. L. Bennett et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody
Kazuhiro Kurosawa et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Update on biomarkers in neuromyelitis optica
Esther Melamed et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Cerebrospinal fluid aquaporin-4-immunoglobulin G disrupts blood brain barrier
Nasrin Asgari et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Experimental Models of Neuromyelitis Optica
Monika Bradl et al.
BRAIN PATHOLOGY (2014)
The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica
Claudia F. Lucchinetti et al.
BRAIN PATHOLOGY (2014)
Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G
Nithi Asavapanumas et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury
Nithi Asavapanumas et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Interferon Alpha Association with Neuromyelitis Optica
Nasrin Asgari et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Neuromyelitis optica-like pathology is dependent on type I interferon response
Reza Khorooshi et al.
EXPERIMENTAL NEUROLOGY (2013)
Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid
Nasrin Asgari et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis
Elisa Schneider et al.
PLOS ONE (2013)
Optic neuritis in neuromyelitis optica
Marc H. Levin et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2013)
HLA, PTPN22 and PD-1 associations as markers of autoimmunity in neuromyelitis optica
N. Asgari et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?
Su-Hyun Kim et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Neuromyelitis optica (NMO) - an autoimmune disease of the central nervous system (CNS)
N. Asgari et al.
ACTA NEUROLOGICA SCANDINAVICA (2011)
A population-based study of neuromyelitis optica in Caucasians
N. Asgari et al.
NEUROLOGY (2011)
Interferon Beta Treatment in Neuromyelitis Optica Increase in Relapses and Aquaporin 4 Antibody Titers
Jacqueline Palace et al.
ARCHIVES OF NEUROLOGY (2010)
Down-Modulation of Programmed Death 1 Alters Regulatory T Cells and Promotes Experimental Autoimmune Encephalomyelitis
Chunhe Wang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Astrocytic damage is far more severe than demyelination in NMO A clinical CSF biomarker study
R. Takano et al.
NEUROLOGY (2010)
Intrathecal Pathogenic Anti-Aquaporin-4 Antibodies in Early Neuromyelitis Optica
Jeffrey L. Bennett et al.
ANNALS OF NEUROLOGY (2009)
Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system
Marco Prinz et al.
IMMUNITY (2008)
IFN-γ-induced chemokines synergize with pertussis toxin to promote T cell entry to the central nervous system
Jason M. Millward et al.
JOURNAL OF IMMUNOLOGY (2007)
Revised diagnostic criteria for neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2006)
NMO-IgG: A specific biomarker for neuromyelitis optica
Brian G. Weinshenker et al.
DISEASE MARKERS (2006)
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
VA Lennon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
The neuro-ophthalmology of multiple sclerosis
EM Frohman et al.
LANCET NEUROLOGY (2005)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
VA Lennon et al.
LANCET (2004)
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
CF Lucchinetti et al.
BRAIN (2002)